Latest Options News

Anax Metals has completed a $2.4 million strategic placement with mining group Gold Valley at a 37.5% premium, while securing a $3.5 million loan to repay convertible notes, positioning the Whim Creek copper project for near-term development.

Norwood Systems has successfully raised $650,000 through an oversubscribed share placement, aiming to fuel its market growth and strategic partnerships in AI-driven voice communication.

Antares Metals Limited (ASX, AM5) has announced a significant acquisition of gold and base metals assets in Western Australia, positioning itself for a maiden drilling campaign in early 2026.

Nido Education Limited has completed the acquisition of two child care services for $6 million, projecting a $1.3 million EBIT boost in 2026. Both services boast occupancy rates above 90%, reinforcing Nido’s incubation growth strategy.

Cobalt Blue Holdings has raised $5.3 million through a discounted placement to advance its Kwinana Cobalt Refinery and Broken Hill projects, reinforcing its position in the critical minerals sector.

Miramar Resources has secured A$1 million through a share placement to fund a targeted RC drilling campaign at its high-potential Gidji JV gold project, while appointing a new director to strengthen its board.

American Rare Earths has appointed mining veteran Mark Wall as CEO to lead its transition from exploration to production, focusing on advancing its flagship Halleck Creek project and expanding its U.S. market presence.

Imugene Limited has received positive feedback from the FDA, aligning key requirements to progress its azer-cel therapy into a pivotal clinical trial, underscoring its growing promise in blood cancer treatment.

Desert Metals has raised $1.25 million to advance drilling and sampling at its promising gold projects in Côte d’Ivoire, aiming to unlock new resource potential in 2026.

Imugene has secured FDA backing to advance its allogeneic CAR T therapy, azer-cel, into a pivotal Phase 3 trial targeting difficult-to-treat diffuse large B-cell lymphoma (DLBCL), including patients relapsed after prior CAR-T treatment.

Telix Pharmaceuticals has dosed the first patient in the randomized expansion phase of its pivotal ProstACT Global Phase 3 trial for TLX591, targeting advanced prostate cancer. The trial is expanding globally, with regulatory submissions underway in the US and Europe.

Chalice Mining’s Pre-Feasibility Study confirms the Gonneville Project as a long-life, low-cost critical minerals mine in Western Australia, projecting A$4.7 billion pre-tax free cashflow over 23 years with rapid payback.